We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

An Open Label Extension Study in Subjects With Fragile X Syndrome (209FX303)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01555333
Recruitment Status : Terminated
First Posted : March 15, 2012
Last Update Posted : July 31, 2013
Information provided by (Responsible Party):
Seaside Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : July 2013
  Study Completion Date : July 2013